Literature DB >> 16820197

Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.

Kizhakke M Sindhu1, Rebecca Banerjee, Karuppagounder S Senthilkumar, Karuppagounder S Saravanan, B China Raju, J Madhusudan Rao, Kochupurackal P Mohanakumar.   

Abstract

Rotenone and 1-methyl-4-phenyl pyridinium (MPP+) are two mitochondrial neurotoxins known to produce Parkinson's disease (PD) in experimental animals. In the present study, we compared drug-induced rotational asymmetry in rats lesioned using these neurotoxins at three distinct basal ganglia sites, the striatum, substantia nigra pars compacta (SNpc) and median forebrain bundle (MFB). The levels of dopamine (DA) in the ipsilateral striata of these hemiparkinsonian animals were assayed employing an HPLC-electrochemical procedure 2 days after the final rotational study. Rats infused with rotenone or MPP+ into the SNpc, but not into the striatum or MFB, exhibited contralateral rotations immediately after recovery from anesthesia. Irrespective of the lesion site or the toxin used, all the animals exhibited ipsilateral rotations when challenged with D-amphetamine. Apomorphine administration caused contralateral circling behavior in MFB-lesioned animals, but ipsilateral rotations in rats that received rotenone or MPP+ in the striatum or SNpc. Stereotaxic administration of rotenone into the MFB, SNpc or striatum caused a significant loss of DA in the ipsilateral striatum to varying degrees (96%, 62% and 30%, respectively, as compared to the contralateral side). However, unilateral MPP+ administration into the MFB, SNpc or striatum caused respectively about 98%, 74% and 59% loss of striatal DA. Behavioural observations and the neurochemical results indicate that, among the three anatomically distinct loci-lesioned, MFB-lesioned animals mimicked behavioral aberrations similar to nigral lesions caused by 6-hydroxydopamine, a classical parkinsonian neurotoxin. Moreover, the results point out that while both d-amphetamine and apomorphine-induced rotations could be considered as valuable behavioral indices to test novel drugs against PD, yet apomorphine-induced contralateral bias proves to be a more reliable indicator of specific destruction in the nigrostriatal pathway and development of post-synaptic DA receptor supersensitivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820197     DOI: 10.1016/j.pbb.2006.05.017

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson's Disease.

Authors:  Xiao Chen; Zhan Liu; Bei-Bei Cao; Yi-Hua Qiu; Yu-Ping Peng
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-20       Impact factor: 4.147

2.  Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats.

Authors:  Reena Haobam; Debasmita Tripathy; Navneet A Kaidery; Kochupurackal P Mohanakumar
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

3.  Striatal neuroprotection with methylene blue.

Authors:  J C Rojas; N Simola; B A Kermath; J R Kane; T Schallert; F Gonzalez-Lima
Journal:  Neuroscience       Date:  2009-07-24       Impact factor: 3.590

4.  Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats.

Authors:  Rebecca Banerjee; Karuppagounder S Saravanan; Bobby Thomas; Kizhake M Sindhu; Kochupurackal P Mohanakumar
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

Review 5.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

6.  Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.

Authors:  Ilse S Pienaar; Timothy Schallert; Suzél Hattingh; William M U Daniels
Journal:  J Neural Transm (Vienna)       Date:  2009-06-06       Impact factor: 3.575

Review 7.  Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease.

Authors:  Anupom Borah; Rajib Paul; Muhammed Khairujjaman Mazumder; Nivedita Bhattacharjee
Journal:  Neurosci Bull       Date:  2013-04-10       Impact factor: 5.203

8.  Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences.

Authors:  Rebecca Banerjee; Sen Sreetama; Karuppagounder S Saravanan; Sailendra Nath Dey; Kochupurackal P Mohanakumar
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

9.  Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.

Authors:  Rajib Paul; Amarendranath Choudhury; Sanjeev Kumar; Anirudha Giri; Rajat Sandhir; Anupom Borah
Journal:  PLoS One       Date:  2017-02-07       Impact factor: 3.240

10.  Engraftment of mouse embryonic stem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats.

Authors:  Debasmita Tripathy; Reena Haobam; Ranju Nair; Kochupurackal P Mohanakumar
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.